The budgets for pharma digitalisation continue to expand at a pace where operational reality is struggling to keep up.
In just four years, AI spending will nearly triple to $11.12bn, up from $4.79bn in 2026
Yet these numbers don’t tell the whole story. Looking at what’s actually happening on the ground – 70% of digital projects are stalling and 89% of workflows are still trapped in spreadsheets. The industry is facing an “execution gap” that needs to be addressed before it gets even wider.
The skill shortage becomes one of the main barriers that’s holding pharma back from reaching digital excellence. Bridging this gap requires direct dialogue between those who build the tech and those who use it on the shop floor. Where is digital transformation becoming faster?